Unusual Hepatitis Spreads; IBD and Erectile Dysfunction; Can PFAS Harm Livers? News and commentary from the world of gastroenterology and hepatology Apr 28, 2022
CDC Issues Advisory on Mystery Hepatitis Cases in Kids Agency eyes adenovirus infection as possible cause behind recently reported cases Apr 22, 2022
Reassuring Data on Two-Dose Hep B Vaccine, Risk of Acute MI No significantly greater risk with Heplisav-B versus Engerix-B Mar 28, 2022
Default Order in Hospitals' EHR Doubles Hepatitis C Screening About 70% of patients completed screening with intervention versus 38% with conventional alert Mar 17, 2022
Getting a Cure to Hepatitis C Patients Who Use Injection Drugs Randomized trial found that HCV care housed at a harm reduction center improved chances Mar 14, 2022
SubQ Infliximab Works for IBD; FDA Clears Complex Colonoscopy Tool; IBS & Diet News and commentary from the world of gastroenterology and hepatology Feb 18, 2022
Universal HCV Screening in Pregnancy Boosts Detection More cases found verses risk-based approach, also IDs perinatal transmission, researcher says Feb 16, 2022
Novel Strategy Slashes HBV Vertical Transmission Sans Immunoglobulin Cambodian study finds antenatal antiviral effective if used for long enough Feb 15, 2022
Recurrent Autoimmune Hepatitis Post-Liver Transplant: What Are the Risks? Probability of recurrent disease more than doubled from 5 to 20 years later Feb 09, 2022
Need for Liver Transplants Rising Sharply in Seniors Post-transplant mortality still higher versus younger patients, but improving over time Nov 17, 2021
FMT Benefits Last a Few Years in Severe Alcoholic Hepatitis Patients More research needed to determine impact on clinical outcomes versus standard of care Nov 14, 2021
Fewer Hepatitis C Patients Seeking Treatment of Late Accelerated declines in 2020 only the latest in a downward trajectory Nov 12, 2021
ACIP: All Adults Ages 59 and Younger Should Get Hep B Vaccine Committee also passed new recommendations on vaccines against Ebola, orthopoxviruses Nov 03, 2021
Advanced Fibrosis Tied to Most Severe Outcomes in NAFLD Study found higher risk of liver decompensation, death in those with bridging fibrosis, cirrhosis Oct 20, 2021
When It Comes to Hep B Vaccine, Three Antigens May Be Better Than One Vaccine licensed in Israel, but not yet in the U.S. Oct 12, 2021
High-Dose HBV Revaccination Better Protects HIV Patients Phase III trial saw more and longer-lasting responses with double the dose Aug 24, 2021
Some Liver Transplant Patients Got Hepatitis B From Donors Injection drug use may be mostly to blame, researcher says Jul 10, 2021
Resmetirom Delivers Promising Outcomes in NASH Without Invasive Follow-Up Real-world study also identifies noninvasive markers for treatment response Jun 29, 2021
Adding PD-1 Inhibitor Shows Promise in Potentially Resectable HCC "Safe and successful conversion therapy" with hepatic arterial infusion chemo plus sintilimab Jun 28, 2021
Tenofovir Treatment Lessened Risk of Severe COVID Infection in HBV But expert questions conclusion of small study from Spain Jun 27, 2021
Bulevirtide Shows Promise in Tough-to-Treat Hepatitis D Significant responses seen with novel agent for "devil" disease Jun 27, 2021
Big Jump in Monthly Average Hospital Admission for Alcoholic Hepatitis Post-Pandemic Long-term impact of alcohol uptake on liver health during COVID-19 crisis remains unknown Jun 26, 2021
The Murky Post-Pandemic Future of Hepatitis C Elimination in the U.S. Modeling study demonstrates need to rebound or risk losing progress Jun 25, 2021
Is Dynamic AFP-R Key to Transplant Selection in Liver Cancer? Dynamic alpha-fetoprotein response improved prediction of patient outcomes May 05, 2021
FDA Panel Splits on Anti-PD-1 Monotherapy in HCC All thumbs up for pembrolizumab, pending further data, but no such luck for nivolumab Apr 30, 2021
Copay Assistance Programs Help Patients but Confuse Them Too Insurers keep track of their use and in some cases won't apply them to patient deductibles Jan 13, 2021
Trial Finds Semaglutide Resolves NASH in Many Obese Adults But "unexpected" lack of improvement in fibrosis stage vs placebo Nov 13, 2020
Fatty Liver Afflicts Most 9/11 'Ground Zero' Workers Researchers blame toxin exposure during recovery and cleanup effort Apr 30, 2020
Respiratory and GI Symptoms? Don't Rule Out COVID-19 Commentary also urges PPE use given potential fecal shedding of virus Mar 17, 2020
Hep B Cure Research: The Long Road Ahead Combination approaches, novel agents may lead the way Jan 03, 2020
ACIP: Hep A and MenB Vaccine Recommendations Updated Hepatitis A recommendations expanded for people with HIV; panel stands pat on flu vaccine policy Jun 28, 2019
Lines Blur Between Non-Alcoholic and Alcoholic Fatty Liver Diagnostic criteria for disease types need updating for better patient stratification Jun 04, 2019
Core Protein Inhibitor: A Key to Eventual HBV Cure? Entecavir plus novel core protein inhibitor led to dramatic declines in hepatitis B DNA, RNA Apr 14, 2019
Combo Tx With 'Entry Inhibitor' Latest Hope in Treating Hep D Myrcludex B and interferon shows promise in HBV/HDV co-infection Apr 12, 2019
Cirrhosis 'Turning Point' in Fatty Liver Progression Most patients identified with decompensated event, real-world study finds Apr 11, 2019
What's Behind London's Falling HCV Rates in HIV+ MSM? City cut HCV incidence in this population by almost 70% in 5 years Mar 08, 2019
Did OxyContin Reformulation Boost HCV Rates? Association suggests "unintended consequence" of abuse deterrent opioids Feb 04, 2019
HCV Combo Pill a Winner in Untreated Cirrhotic Patients High SVR12 rate suggests 8-week treatment could be used for this population Nov 14, 2018
